VMED Stock Overview
Engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Viromed Medical AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €2.00 |
52 Week High | €2.40 |
52 Week Low | €1.80 |
Beta | 0 |
11 Month Change | 0.50% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -6.54% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
VMED | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 1.0% | -0.4% | -0.4% |
1Y | n/a | -7.1% | 7.1% |
Return vs Industry: Insufficient data to determine how VMED performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how VMED performed against the German Market.
Price Volatility
VMED volatility | |
---|---|
VMED Average Weekly Movement | 9.5% |
Medical Equipment Industry Average Movement | 5.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 11.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: VMED's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine VMED's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2021 | n/a | n/a | www.viromed-medical-ag.de |
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.
Viromed Medical AG Fundamentals Summary
VMED fundamental statistics | |
---|---|
Market cap | €39.29m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs VMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VMED income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did VMED perform over the long term?
See historical performance and comparison